Lotus Eye Hospital And Institute Ltd.

NSE: LOTUSEYE BSE: 532998 SECTOR: Hospital & Healthcare Services  13k   39   3

59.99
+1.14 (1.94%)
NSE: 29 Mar 4:00 PM

Price Summary

Today's High

₹ 60.4

Today's Low

₹ 56.7

52 Week High

₹ 96.9

52 Week Low

₹ 42

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

124.76 Cr.

Enterprise Value

116.05 Cr.

No. of Shares

2.08 Cr.

P/E

31.42

P/B

2.19

Face Value

₹ 10

Div. Yield

0.83 %

Book Value (TTM)

₹  27.42

CASH

8.85 Cr.

DEBT

0.14 Cr.

Promoter Holding

58.14 %

EPS (TTM)

₹  1.91

Sales Growth

20.21%

ROE

5.56 %

ROCE

8%

Profit Growth

90.33 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year20.21%
3 Year0.42%
5 Year2.76%

Profit Growth

1 Year90.33%
3 Year61.54%
5 Year46.38%

ROE%

1 Year5.56%
3 Year3.56%
5 Year3.11%

ROCE %

1 Year8%
3 Year5.13%
5 Year4.15%

Debt/Equity

0.0025

Price to Cash Flow

28.39

Interest Cover Ratio

20.0839160839161

CFO/PAT (5 Yr. Avg.)

2.73459122613576

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2022 58.14 4.14
Sep 2022 57.88 4.15
Jun 2022 57.74 4.16
Mar 2022 57.74 0
Dec 2021 57.74 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 61.5379589455962% for the Past 3 years.
  • The company has significantly decreased its debt by 0.1269 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 20.0839160839161.
  • Company’s PEG ratio is 0.34788315422645.
  • The company has an efficient Cash Conversion Cycle of -65.0255443938726 days.
  • Company has a healthy liquidity position with current ratio of 2.23669246152508.
  • The company has a good cash flow management; CFO/PAT stands at 2.73459122613576.
  • The company has a high promoter holding of 58.14%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.34409354087592.

 Limitations

  • The company has shown a poor revenue growth of 0.418889149382196% for the Past 3 years.
  • Company has a poor ROE of 3.55984196843957% over the past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 11.61 10.57 11.87 11.86 12.14
Total Expenditure 9.25 9.32 9.55 10.11 10.02
Operating Profit 2.35 1.25 2.32 1.75 2.12
Other Income 0.22 0.29 0.24 0.23 0.32
Interest 0.04 0.04 0.03 0.03 0.02
Depreciation 0.63 0.75 0.68 0.75 0.77
Exceptional Items 0 -0.01 0 0 0
Profit Before Tax 1.9 0.75 1.85 1.21 1.64
Tax 0.51 0.2 0.48 0.31 0.49
Profit After Tax 1.39 0.54 1.37 0.9 1.16
Adjusted EPS (Rs) 0.67 0.26 0.66 0.43 0.56

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 38.02 38.43 40.55 32.37 38.91
Total Expenditure 33.67 35.2 36.57 28.73 32.98
Operating Profit 4.35 3.22 3.98 3.64 5.93
Other Income 0.86 0.68 0.9 0.74 0.89
Interest 0.18 0.21 0.24 0.14 0.21
Depreciation 3.37 3.06 2.5 2.33 2.5
Exceptional Items 0.04 0 -0.69 0.08 -0.01
Profit Before Tax 1.7 0.63 1.46 1.99 4.09
Tax -0.04 -0.08 0.39 0.42 1.11
Net Profit 1.75 0.71 1.06 1.57 2.98
Adjusted EPS (Rs.) 0.84 0.34 0.51 0.75 1.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 20.8 20.8 20.8 20.8 20.8
Total Reserves 29.84 29.32 30.46 31.9 33.81
Borrowings 0.09 0 0 0 0
Other N/C liabilities -0.31 -0.22 0.13 -0.06 0.71
Current liabilities 6.99 5.62 5.87 5.82 5.75
Total Liabilities 57.41 55.52 57.26 58.46 61.07
Assets
Net Block 42.52 44.14 42.67 40.54 44.07
Capital WIP 0.29 0.29 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 4.64 4.35 4.07 4.31 4.14
Other N/C Assets 1.88 0.15 0 0 0
Current Assets 8.09 6.59 10.52 13.6 12.86
Total Assets 57.41 55.52 57.26 58.46 61.07
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 1.66 0.63 2.15 1.91 4.1
Adjustment 3.28 2.45 1.82 1.78 1.88
Changes in Assets & Liabilities 1.22 1.25 1.27 -0.66 -0.75
Tax Paid -0.38 -0.13 -0.27 -0.3 -0.85
Operating Cash Flow 5.78 4.2 4.97 2.73 4.39
Investing Cash Flow -3.86 -4.01 -0.68 0.49 -3.92
Financing Cash Flow -1.51 -1.41 0.13 -0.32 -1.58
Net Cash Flow 0.41 -1.22 4.42 2.9 -1.1

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Promoters 57.74 57.74 57.74 57.88 58.14
kaliannagounder su... 2.41 2.41 - 2.41 2.41
kavetha sundaramoo... 18.78 18.78 18.78 18.78 18.78
kaliannagounder su... - - - - -
sangeetha s 18.84 18.84 18.84 18.84 18.84
s rajkumar 17.71 17.71 17.71 17.85 18.10
late kaliannagound... - - 2.41 - -
sangeetha s. - - - - -
kavetha sundramoor... - - - - -
PARTICULARS Dec 2021% Mar 2022% Jun 2022% Sep 2022% Dec 2022%
Investors 42.26 42.26 42.26 42.12 41.86
kovai purani finan... 6.33 6.33 6.33 6.33 6.33
vramath investment... 4.81 4.81 4.81 4.81 4.84
vramath investment... - - - - -
vramath investment... - - - - -
vramath financial ... - - 1.74 4.41 4.81
sangeeta choudhary - - - 3.18 -
sangeetha choudhary - - - - -
sangeeta choudhary 3.61 3.58 3.58 - 2.17
rajesh madhavan un... 2.04 2.04 - - -
mahendran devika 2.02 2.02 2.02 2.02 2.01
dr. rajeev choudha... - - - - -
rajesh madhavan uni - - - - -
rajesh madhavan un... - - - - -
k s ramalingam 1.43 1.43 1.43 1.43 1.43
santosh thomas - - - - -
thomas santosh 1.01 1.01 1.01 - -
llp 0.02 - 0.01 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationQ4FY21 29 Jul 2021
  • PresentationQ3FY21 11 Feb 2021

Company News

Lotus Eye Hospital and Institute informs about closure of trading window30 Mar 2023, 12:10PM Lotus Eye Hospital And Institute informs about newspaper publication 15 Feb 2023, 12:00PM Lotus Eye Hospital - Quaterly Results13 Feb 2023, 6:43PM Lotus Eye Hospital And Institute informs about certificate7 Jan 2023, 10:28AM Lotus Eye Hospital and Institute informs about closure of trading window31 Dec 2022, 2:45PM Lotus Eye Hospital And Institute informs about appointment of director 21 Dec 2022, 12:25PM Lotus Eye Hospital And Institute informs about newspaper advertisement16 Nov 2022, 9:50AM Lotus Eye Hospital And Institute informs about board meeting 5 Nov 2022, 2:32PM Lotus Eye Hospital And Institute informs about final dividend23 Sep 2022, 4:56PM Lotus Eye Hospital And Institute informs about newspaper advertisement1 Sep 2022, 3:24PM Lotus Eye Hospital And Institute informs about book closure30 Aug 2022, 4:27PM Lotus Eye Hospital - Quaterly Results9 Aug 2022, 5:49PM Lotus Eye Hospital - Quaterly Results9 Aug 2022, 5:49PM Lotus Eye Hospital and Institute informs about board meeting intimation 30 Jul 2022, 11:00AM Lotus Eye Hospital And Institute informs about closure of trading window30 Jun 2022, 9:49AM Lotus Eye Hospital And Institute informs about newspaper publication 27 May 2022, 11:28AM Lotus Eye Hospital - Quaterly Results25 May 2022, 8:32PM Lotus Eye Hospital - Quaterly Results25 May 2022, 8:32PM Lotus Eye Hospital And Institute informs about board meeting16 May 2022, 12:15PM Lotus Eye Hospital And Institute informs about board meeting16 May 2022, 10:22AM Lotus Eye Hospital and Institute informs about non applicability of large entity30 Apr 2022, 10:40AM Lotus Eye Hospital And Institute informs about disclosure18 Apr 2022, 10:36AM Lotus Eye Hospital And Institute informs about resignation of CFO26 Mar 2022, 9:36AM Lotus Eye Hospital And Institute informs about disclosure8 Mar 2022, 2:31PM Lotus Eye Care Hospital and Institute informs about appointment of CS cum CO15 Feb 2022, 10:12AM Lotus Eye Hospital and Institute informs about outcome of AGM18 Sep 2021, 4:58PM Lotus Eye Hospital and Institute informs about disclosure of related party transactions17 Jul 2021, 12:21PM Lotus Eye Hospital And Institute informs about reconstitution of audit committee14 Jun 2021, 2:30PM Lotus Eye Hospital And Institute informs about certificate17 Apr 2021, 3:48PM Lotus Eye Hospital And Institute informs about board meeting16 Jan 2021, 11:05AM Lotus Eye Hospital and Institute informs about board meeting26 Oct 2020, 11:13AM

Lotus Eye Hospital Stock Price Analysis and Quick Research Report. Is Lotus Eye Hospital an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Lotus Eye Hospital and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 4.3939 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Lotus Eye Hospital has a Debt to Equity ratio of 0.0025 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Lotus Eye Hospital , the EPS growth was 90.3315649867374 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Lotus Eye Hospital has OPM of 15.2485614201013 % which is a good sign for profitability.
     
  • ROE: Lotus Eye Hospital have a poor ROE of 5.56244658931106 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Lotus Eye Hospital

X